| Ident. | Authors (with country if any) | Title |
|---|
| 000144 |
Zanfina Ademi [Australie] ; Danny Liew [Australie] ; Alexandra Gorelik [Australie] ; Megan Bohensky [Australie] ; Ella Zomer [Australie] ; Bruce Hollingsworth [Royaume-Uni] ; Gabriel Steg [France] ; Deepak L. Bhatt [États-Unis] ; Christopher M. Reid [Australie] | Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data |
| 000393 |
Pierre Amarenco [France] ; Stephen Davis [Australie] ; Elizabeth F. Jones [Australie] ; Ariel A. Cohen [France] ; Wolf-Dieter Heiss [Allemagne] ; Markku Kaste [Finlande] ; Cédric Laouenan [France] ; Dennis Young [Australie] ; Malcolm Macleod [Australie, Royaume-Uni] ; Geoffrey A. Donnan [Australie] | Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques |
| 000533 |
Robert S. Rosenson [États-Unis] ; H. Bryan Jr Brewer [États-Unis] ; Benjamin Ansell [États-Unis] ; Philip Barter [Australie] ; M. John Chapman [France] ; Jay W. Heinecke [États-Unis] ; Anatol Kontush [France] ; Alan R. Tall [États-Unis] ; Nancy R. Webb [États-Unis] | Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges |
| 000582 |
Zanfina Ademi [Australie] ; Molla M. Huq [Australie] ; Danny Liew [Australie] ; Ph. Gabriel Steg [France] ; Deepak L. Bhatt [États-Unis] ; Mark Nelson [Australie] ; Christopher M. Reid [Australie] | The Impact of Lost Therapeutic Benefit (LTB) in High-Risk Hypertensive Patients: 2-Year Follow-Up Data from the Australian REACH Registry |
| 000604 |
Elisabeth Lambert [Australie] ; Yves D'Udekem [Australie] ; Michael Cheung [Australie] ; Carolina Ika Sari [Australie] ; Julia Inman [Australie] ; Anna Ahimastos [Australie] ; Nina Eikelis [Australie] ; Atul Pathak [France] ; Ingrid King [Australie] ; Leanne Grigg [Australie] ; Markus Schlaich [Australie] ; Gavin Lambert [Australie] | Sympathetic and vascular dysfunction in adult patients with Fontan circulation |
| 000699 |
Arjan J. Kwakernaak [Pays-Bas] ; Gilles Lambert [Australie, France] ; Maartje C. J. Slagman [Pays-Bas] ; Femke Waanders [Pays-Bas] ; Gozewijn D. Laverman [Pays-Bas] ; Francine Petrides [Australie] ; Bert D. Dikkeschei [Pays-Bas] ; Gerjan Navis [Pays-Bas] ; Robin P. F. Dullaart [Pays-Bas] | Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment |
| 000933 |
Matthieu Plichart [France] ; Frederique Thomas [France] ; Jean-Philippe Empana [France] ; Kathryn Bean [France] ; Marie-Cécile Perier [France] ; David S. Celermajer [Australie] ; Olivier Hanon [France] ; Nicolas Danchin [France] ; Bruno Pannier [France] ; Xavier Jouven [France] | Gender-specific trends in heart rate in the general population from 1992-2007: a study of 226,288 French adults |
| 000934 |
Bronwyn A. Kingwell [Australie] ; M. John Chapman [France] | Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular Disease |
| 000A27 |
Frédéric Dutheil [France, Australie] ; Gérard Lac [France] ; Bruno Lesourd [France] ; Robert Chapier [France] ; Guillaume Walther [France] ; Agnès Vinet [France] ; Vincent Sapin [France] ; Julien Verney [France] ; Lemlih Ouchchane [France] ; Martine Duclos [France] ; Philippe Obert [Australie, France] ; Daniel Courteix [France, Australie] | Different modalities of exercise to reduce visceral fat mass and cardiovascular risk in metabolic syndrome: the RESOLVE* randomized trial |
| 000A76 |
Rishi Puri [États-Unis] ; Steven E. Nissen [États-Unis] ; Peter Libby [États-Unis] ; Mingyuan Shao [États-Unis] ; Christie M. Ballantyne [États-Unis] ; Phillip J. Barter [Australie] ; M. John Chapman [France] ; Raimund Erbel [Allemagne] ; Joel S. Raichlen [Australie] ; Kiyoko Uno [États-Unis] ; Yu Kataoka [États-Unis] ; Stephen J. Nicholls [États-Unis, Australie] | C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy |
| 000E79 |
Christopher M. Reid [Australie] ; Zanfina Ademi [Australie] ; Mark R. Nelson [Australie] ; Greg Connor [Australie] ; Derek P. Chew [Australie] ; Louise Shiel [Australie] ; Ana Smeath [Australie] ; Fred De Looze [Australie] ; Ph Gabriel Steg [France] ; Deepak L. Bhatt [États-Unis] ; Danny Liew [Australie] | Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis |
| 001010 |
Priscila Ramos-Mozo [Espagne] ; Julio Madrigal-Matute [Espagne] ; Melina Vega De Ceniga [Espagne] ; Luis Miguel Blanco-Colio [Espagne] ; Olivier Meilhac [France] ; Laurent Feldman [France] ; Jean-Baptiste Michel [France] ; Paula Clancy [Australie] ; Jonathan Golledge [Australie] ; Paul E. Norman [Australie] ; Jesus Egido [Australie] ; Jose Luis Martin-Ventura [Espagne] | Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm |
| 001326 |
Andrew I. U. Shearn [France] ; Virginie Deswaerte [France, Australie] ; Emmanuel L. Gautier [France] ; Flora Saint-Charles [France] ; John Pirault [France] ; Laura Bouchareychas [France] ; Edmund B. Iii Rucker [France] ; Sophie Beliard [France] ; John Chapman [France] ; Wendy Jessup [Australie] ; Thierry Huby [France] ; Philippe Lesnik [France] | Bcl-x Inactivation in Macrophages Accelerates Progression of Advanced Atherosclerotic Lesions in Apoe-/- Mice |
| 001520 |
M. John Chapman [France] ; Henry N. Ginsberg [États-Unis] ; Pierre Amarenco [France] ; Felicita Andreotti [Italie] ; Jan Boren [Suède] ; Alberico L. Catapano [Italie] ; Olivier S. Descamps [Belgique] ; Edward Fisher [États-Unis] ; Petri T. Kovanen [Finlande] ; Jan Albert Kuivenhoven [Pays-Bas] ; Philippe Lesnik [France] ; Luis Masana [Espagne] ; Borge G. Nordestgaard [Danemark] ; Kausik K. Ray [Royaume-Uni] ; Zeljko Reiner [Croatie] ; Marja-Riitta Taskinen [Finlande] ; Lale Tokgözoglu [Turquie] ; Anne Tybjaerg-Hansen [Danemark] ; Gerald F. Watts [Australie] | Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management |
| 001681 |
Jonathan Golledge [Australie] ; Ziad Mallat [France, Royaume-Uni] ; Alain Tedgui [France] ; Paul E. Norman [Australie] | Serum secreted phospholipase A2 is associated with abdominal aortic aneurysm presence but not progression |
| 001713 |
Paul J. W. H. Kappelle [Pays-Bas] ; Gilles Lambert [Australie, France] ; Björn Dahlb Ck [Suède, Pays-Bas] ; Lars Bo Nielsen [Danemark] ; Robin P. F. Dullaart [Suède, Pays-Bas] | Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects |
| 001783 |
Paul J. W. H. Kappelle [Pays-Bas] ; Gilles Lambert [Australie, France] ; Robin P. F. Dullaart [Pays-Bas] | Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24 h insulin infusion in healthy subjects and type 2 diabetic patients |
| 001789 |
M. John Chapman [France] | Pitavastatin: Novel effects on lipid parameters |
| 001900 |
Michael R. Skilton [Australie] ; Jaye P. F. Chin-Dusting [Australie] ; Anthony M. Dart [Australie] ; Laima Brazionis [Australie] ; Olivier Lantieri [France] ; Kerin O'Dea [Australie] ; Beverley Balkau [Australie, France] | Metabolic health, obesity and 9-year incidence of peripheral arterial disease: The D.E.S.I.R. study |
| 001931 |
Fatiha Tabet [Australie] ; Gilles Lambert [Australie, France] ; Luisa F. Cuesta Torres [Australie] ; LIMING HOU [Australie] ; Irene Sotirchos [Australie] ; Rhian M. Touyz [Canada] ; Alicia J. Jenkins [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] | Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages |
| 001A12 |
YING ZHAO [Pays-Bas] ; Marieke Pennings [Pays-Bas] ; Carlos Lj. Vrins [Pays-Bas] ; Laura Calpe-Berdiel [Pays-Bas] ; Menno Hoekstra [Pays-Bas] ; J. Kar Kruijt [Pays-Bas] ; Roelof Ottenhoff [Pays-Bas] ; Reeni B. Hildebrand [Pays-Bas] ; Ronald Van Der Sluis [Pays-Bas] ; Wendy Jessup [Australie] ; Wilfried Le Goff [France] ; M. John Chapman [France] ; Thierry Huby [France] ; Albert K. Groen [Pays-Bas] ; Theo J. C. Van Berkel [Pays-Bas] ; Miranda Van Eck [Pays-Bas] | Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI |
| 001C87 |
Matthieu Plichart [France] ; David S. Celermajer [Australie] ; Mahmoud Zureik [France] ; Catherine Helmer [France] ; Xavier Jouven [France] ; Karen Ritchie [France, Royaume-Uni] ; Christophe Tzourio [France] ; Pierre Ducimetiere [France] ; Jean-Philippe Empana [France] | Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study |
| 001C88 |
Michael R. Skilton [Australie, France] ; Loic Boussel [France] ; Fabrice Bonnet [France] ; Sophie Bernard [France] ; Philippe Charles Douek [France] ; Philippe Moulin [France] ; Andre Serusclat [France] | Carotid intima-media and adventitial thickening: Comparison of new and established ultrasound and magnetic resonance imaging techniques |
| 001F64 |
Zanfina Ademi [Australie] ; Danny Liew [Australie] ; Bruce Hollingsworth [Australie] ; Rory Wolfe [Australie] ; Gabriel P. Steg [France] ; Deepak L. Bhatt [États-Unis] ; Christopher M. Reid [Australie] | The Economic Implications of Treating Atherothrombotic Disease in Australia, From the Government Perspective |
| 001F69 |
Fatiha Tabet [Australie] ; Alan T. Remaley [États-Unis] ; Aude I. Segaliny [Australie] ; Jonathan Millet [Australie] ; LING YAN [Australie] ; Shirley Nakhla [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] ; Gilles Lambert [France] | The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro |
| 002130 |
Charatambos Vlachopoulos [Grèce] ; Konstantinos Aznaouridis [Grèce] ; Michael F. O'Rourke [Australie] ; Michel E. Safar [France] ; Katerina Baou [Grèce] ; Christodoulos Stefanadis [Grèce] | Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis |
| 002203 |
Estelle Nobecourt [Australie] ; Fatiha Tabet [Australie] ; Gilles Lambert [Australie] ; Rajesh Puranik [Australie] ; SHISAN BAO [Australie] ; LING YAN [Australie] ; Michael J. Davies [Australie] ; Bronwyn E. Brown [Australie] ; Alicia J. Jenkins [France] ; Gregory J. Dusting [Australie] ; David J. Bonnet [Australie] ; Linda K. Curtiss [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [États-Unis] | Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I |
| 002292 |
B Rge G. Nordestgaard [Danemark] ; M. John Chapman [France] ; Kausik Ray [Royaume-Uni] ; Jan Boren [Suède] ; Felicita Andreotti [Italie] ; Gerald F. Watts [Australie] ; Henry Ginsberg [États-Unis] ; Pierre Amarenco [France] ; Alberico Catapano [Italie] ; Olivier S. Descamps [Belgique] ; Edward Fisher [États-Unis] ; Petri T. Kovanen [Finlande] ; Jan Albert Kuivenhoven [Pays-Bas] ; Philippe Lesnik [France] ; Luis Masana [Espagne] ; Zeljko Reiner [Croatie] ; Marja-Riitta Taskinen [Finlande] ; Lale Tokgözoglu [Turquie] ; Anne Tybjaerg-Hansen [Danemark] | Lipoprotein(a) as a cardiovascular risk factor: current status |
| 002475 |
Z. Ademi [Australie] ; H. L. Walls [Australie] ; A. Peeters [Australie] ; D. Liew [Australie] ; B. Hollingsworth [Australie] ; C. Stevenson [Australie] ; Ph-G Steg [France] ; D. L. Bhatt [États-Unis] ; C. M. Reid [Australie] | Economic implications of obesity among people with atherothrombotic disease |
| 002564 |
Michael R. Skilton [Australie] ; Fabrice Bonnet [France] ; Lisa M. Begg [Australie] ; Markus Juonala [Finlande] ; Mika K Hönen [Finlande] ; Terho Lehtim Ki [Finlande] ; Jorma S. A. Viikari [Finlande] ; Olli T. Raitakari [Finlande] | Childbearing, Child-Rearing, Cardiovascular Risk Factors, and Progression of Carotid Intima-Media Thickness: The Cardiovascular Risk in Young Finns Study |
| 002615 |
A. Koïtka [Australie] ; Z. Cao [Australie] ; P. Koh [Australie] ; A. M. D. Watson [Australie] ; K. C. Sourris [Australie] ; L. Loufrani [France] ; A. Soro-Paavonen [Australie] ; T. Walther [Royaume-Uni] ; K. J. Woollard [Australie] ; K. A. M. Jandeleit-Dahm [Australie] ; M. E. Cooper [Australie] ; T. J. Allen [Australie] | Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes |
| 002825 |
Sandra Larrede [France] ; Carmel M. Quinn [Australie] ; Wendy Jessup [Australie] ; Eric Frisdal [France] ; Maryline Olivier [France] ; Victar Hsieh [Australie] ; Mi-Jurng Kim [Australie] ; Miranda Van Eck [Pays-Bas] ; Philippe Couvert [France] ; Alain Carrie [France] ; Philippe Giral [France] ; M. John Chapman [France] ; Maryse Guerin [France] ; Wilfried Le Goff [France] | Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but AB CG1-Independent |
| 002946 |
Michael R. Skilton [Australie, France] ; André Serusclat [France] ; Lisa M. Begg [Australie] ; Philippe Moulin [France] ; Fabrice Bonnet [France] | Parity and Carotid Atherosclerosis in Men and Women : Insights Into the Roles of Childbearing and Child-Rearing |
| 002986 |
Gilles Lambert [Australie, France] ; Francesca Charlton [Australie] ; Kerry-Anne Rye [Australie] ; Derek E. Piper [États-Unis] | Molecular basis of PCSK9 function |
| 002A36 |
XIAOCHUN LI [Australie] ; Milena Stankovic [Australie] ; Boris P.-L. Lee [Suisse] ; Michel Aurrand-Lions [France] ; Chris N. Hahn [Australie] ; YING LU [Australie] ; Beat A. Imhof [Suisse] ; Mathew A. Vadas [Australie] ; Jennifer R. Gamble [Australie] | JAM-C Induces Endothelial Cell Permeability Through Its Association and Regulation of β3 Integrins |
| 002E21 |
Robert J. Macfadyen [Royaume-Uni] ; M. Jennyfer Ng Kam Chuen [Royaume-Uni] ; Malcolm J. West [Australie] ; Paul J. Nestel [Australie] ; Adrienne C. Kirby [Australie] ; Renate Schnabel [Allemagne] ; David Sullivan [Australie] ; R. John Simes [Australie] ; Christine Pollicino [Australie] ; Edith Lubos [Allemagne] ; Thomas F. Münzel [Allemagne] ; Harvey D. White [Nouvelle-Zélande] ; Andrew M. Tonkin [Australie] ; Christoph Bickel [Allemagne] ; Laurence Tiret [France] ; Stefan Blankenberg [Allemagne] | The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. Commentary |
| 003090 |
Denis Lairon [France] | Macronutrient intake and modulation on chylomicron production and clearance |
| 003151 |
John W. Eikelboom [Canada] ; Graeme J. Hankey [Australie] ; Jim Thorn [Australie] ; Deepak L. Bhatt [États-Unis] ; P. Gabriel Steg [France] ; Gilles Montalescot [France] ; S. Claiborne Johnston [États-Unis] ; Steven R. Steinhubl [États-Unis] ; Koon-Hou Mak [Singapour] ; J. Donald Easton [États-Unis] ; Christian Hamm [Allemagne] ; TINGFEI HU [États-Unis] ; Keith A. A. Fox [Royaume-Uni] ; Eric J. Topol [États-Unis] | Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid : Determinants and Effect on Cardiovascular Risk |
| 003176 |
Vivienne M. Homer [Nouvelle-Zélande] ; A. David Marais [Afrique du Sud] ; Francesca Charlton [Australie] ; Andrew D. Laurie [Nouvelle-Zélande] ; Nicola Hurndell [Nouvelle-Zélande] ; Russel Scott [Nouvelle-Zélande] ; Fabien Mangili [Australie] ; David R. Sullivan [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] ; Peter M. George [Nouvelle-Zélande] ; Gilles Lambert [Australie, France] | Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa |
| 003646 |
Maaike Kockx [Australie] ; Dongni Lily Guo [Australie] ; Thierry Huby [France] ; Philippe Lesnik [France] ; Jason Kay [Australie] ; Tharani Sabaretnam [Australie] ; Eve Jary [Australie] ; Michael Hill [Australie] ; Katharina Gaus [Australie] ; John Chapman [France] ; Jennifer L. Stow [Australie] ; Wendy Jessup [Australie] ; Leonard Kritharides [Australie] | Secretion of apolipoprotein e from macrophages occurs via a protein kinase A-and calcium-dependent pathway along the microtubule network |
| 003775 |
Leopold Fezeu [France, Cameroun] ; Beverley Balkau [France] ; André-Pascal Kengne [Cameroun, Australie] ; Eugène Sobngwi [Cameroun] ; Jean-Claude Mbanya [Cameroun] | Metabolic syndrome in a sub-Saharan African setting: Central obesity may be the key determinant |
| 003936 |
Prakash Deedwania [États-Unis] ; Peter H. Stone [États-Unis] ; C. Noel Bairey Merz [États-Unis] ; Juan Cosin-Aguilar [Espagne] ; Nevres Koylan [Turquie] ; DON LUO [États-Unis] ; Pamela Ouyang [États-Unis] ; Ryszard Piotrowicz [Pologne] ; Karin Schenck-Gustafsson [Suède] ; Philippe Sellier [France] ; James H. Stein [États-Unis] ; Peter L. Thompson [Australie] ; Dan Tzivoni [Israël] | Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease : Results of the study assessing goals in the elderly (SAGE) |
| 003A47 |
Robyn J. Tapp [France, Australie] ; Beverley Balkau [France] ; Jonathan E. Shaw [Australie] ; Paul Valensi [France] ; Martine Cailleau [France] ; Eveline Eschwege [France] | Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease : The DESIR study |
| 004085 |
Patrick W. G. Mallon [Australie] ; John Miller [Australie] ; Jason C. Kovacic [Australie] ; Julia Kent-Hughes [Australie] ; Richard Norris [Australie] ; Katherine Samaras [Australie, France] ; Michael P. Feneley [Australie] ; David A. Cooper [Australie] ; Andrew Carr [Australie] ; Shahin Gharakhanian [France, États-Unis] ; Franck Boccara [France] ; Jacqueline Capeau [France] | Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men : a randomized, placebo-controlled study. Commentary |
| 004156 |
Deepak L. Bhatt [États-Unis] ; Keith A. A. Fox [Royaume-Uni] ; Werner Hacke [Allemagne] ; Peter B. Berger [États-Unis] ; Henry R. Black [États-Unis] ; William E. Boden [États-Unis] ; Patrice Cacoub [France] ; Eric A. Cohen [Canada] ; Mark A. Creager [États-Unis] ; J. Donald Easton [États-Unis] ; Marcus D. Flather [Royaume-Uni] ; Steven M. Haffner [États-Unis] ; Christian W. Hamm [Allemagne] ; Graeme J. Hankey [Australie] ; S. Claiborne Johnston [États-Unis] ; Koon-Hou Mak [Singapour] ; Jean-Louis Mas [France] ; Gilles Montalescot [France] ; Thomas A. Pearson [États-Unis] ; P. Gabriel Steg ; Steven R. Steinhubl ; Michael A. Weber ; Danielle M. Brennan [États-Unis] ; Liz Fabry-Ribaudo [États-Unis] ; Joan Booth [États-Unis] ; Eric J. Topol | Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events |
| 004198 |
P. J. Barter [Australie] ; C. M. Ballantyne [États-Unis] ; R. Carmena [Espagne] ; M. Castro Cabezas [Pays-Bas] ; M. John Chapman [France] ; P. Couture [Canada] ; J. De Graaf [Pays-Bas] ; P. N. Durrington [Royaume-Uni] ; O. Faergeman [Danemark] ; J. Frohlich [Canada] ; C. D. Furberg [États-Unis] ; C. Gagne [Canada] ; S. M. Haffner [États-Unis] ; S. E. Humphries [Royaume-Uni] ; I. Juncner [Suède] ; R. M. Krauss ; P. Kwiterovich ; S. Marcovina ; C. J. Packard ; T. A. Pearson ; K. Srinath Reddy ; R. Rosenson ; N. Sarrafzadegan ; A. D. Sniderman ; A. F. Stalenhoef [Pays-Bas] ; E. Stein ; P. J. Talmud [Royaume-Uni] ; A. M. Tonkin ; G. Walldius ; K. M. S. Williams [États-Unis] | Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy : report of the thirty-person/tencountry panel |
| 004579 |
B. K. Kr Mer [Allemagne] ; H.-H. Neumayer [Allemagne] ; R. Stahl [Allemagne] ; M. Pietrzyk [Allemagne] ; B. Krüger [Allemagne] ; B. Pfalzer [Allemagne] ; B. Bourbigot [France] ; S. Campbell [Australie] ; J. Whelchel [États-Unis] ; J. Eris [Australie] ; S. Vitko [République tchèque] ; K. Budde [Allemagne] | Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab |
| 004931 |
Pierre Amarenco [France] ; Andrew M. Tonkin [Australie] | Statins for stroke prevention : Disappointment and hope |
| 004964 |
Jacques Amar [France] ; Jean-Bernard Ruidavets [France] ; Claire Bal Dit Sollier [France] ; Vanina Bongard [France] ; Henri Boccalon [France] ; Bernard Chamontin [France] ; Ludovic Drouet [France] ; Jean Ferrieres [France] ; Alberto Avolio [Australie] | Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness. Commentary |
| 004C18 |
K. Borch-Johnsen [Danemark] ; S. Colagiuri [Australie] ; B. Balkau [France] ; C. Glümer [Danemark] ; B. Carstensen [Danemark] ; A. Ramachandran [Inde] ; Y. Dong [République populaire de Chine] ; W. Gao [République populaire de Chine] | Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia |
| 004E34 |
Eric J. Topol [États-Unis] ; Donald Easton [États-Unis] ; Robert A. Harrington [États-Unis] ; Pierre Amarenco [France] ; Robert M. Califf [États-Unis] ; Carmen Graffagnino [États-Unis] ; Stephen Davis [Australie] ; Hans-Christophe Diener [Allemagne] ; James Ferguson [Irlande (pays)] ; Desmond Fitzgerald [Irlande (pays)] ; Jeffrey Granett ; Ashfaq Shuaib [Canada] ; Peter J. Koudstaal [Pays-Bas] ; Pierre Theroux [Canada] ; Frans Van De Werf [Belgique] ; Kristina Sigmon [États-Unis] ; Karen Pieper [États-Unis] ; Marc Vallee [États-Unis] ; James T. Willerson [États-Unis] | Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease |
| 005041 |
Philip J. Barter [Australie] ; H. Bryan Jr Brewer [États-Unis] ; M. John Chapman [France] ; Charles H. Hennekens [Norvège] ; Daniel J. Rader [États-Unis] ; Alan R. Tall [États-Unis] | Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis |
| 005338 |
Bruno M. Pannier [France] ; Alberto P. Avolio [Australie] ; Arnold Hoeks [Pays-Bas] ; Giuseppe Mancia [Italie] ; Kenji Takazawa [Japon] | Methods and devices for measuring Arterial compliance in humans |
| 005358 |
Aernout Luttun [Belgique] ; Florea Lupu [États-Unis] ; Erik Storkebaum [Belgique] ; Marc F. Hoylaerts [Belgique] ; Lieve Moons [Belgique] ; James Crawley [États-Unis] ; Francoise Bono [France] ; A. Robin Poole [Canada] ; Peter Tipping [Australie] ; Jean-Marc Herbert [France] ; Désiré Collen [Belgique] ; Peter Carmeliet [Belgique] | Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice |
| 005478 |
John B. Kostis [États-Unis] ; Stuart Cobbe [Royaume-Uni] ; Colin Johnston [Australie] ; Ian Ford [Royaume-Uni] ; Michael Murphy [Irlande (pays)] ; Michael A. Weber [États-Unis] ; Henry R. Black [France] ; Pierre Francois Plouin [France] ; Daniel Levy [États-Unis] ; Guiseppe Mancia [Italie] ; Pierre Larochelle [Canada] ; Rainer E. Kolloch [Allemagne] ; Michael Alderman [États-Unis] ; Luis Miguel Ruilope [Espagne] ; Björn Dahlöf [Suède] ; John M. Flack [États-Unis] ; Robert Wolf [États-Unis] | Design of the Omapatrilat in Persons with Enhanced Risk of atherosclerotic events (OPERA) trial |
| 006800 |
N. Niederhoffer [France] ; Yu. V. Bobryshev [Australie] ; I. Lartaud-Idjouadiene [France] ; P. Giummelly [France] ; J. Atkinson [France] | Aortic calcification produced by vitamin D3 plus nicotine |
| 006C85 |
A. Simon [France] ; J. Levenson | Early detection of subclinical atherosclerosis in asymptomatic subjects at high risk for cardiovascular disease |
